Michaela Ann Dinan, PhD

Associate Professor in Population Health Sciences
Assistant Professor in Medicine
Membership in the Duke Clinical Research Institute
Campus mail 215 Morris St, Duke Box 104023, Durham, NC 27701
Phone (919) 668-8177
Email address michaela.dinan@duke.edu

Dr. Dinan is a health services researcher with a focus on emerging medical technology in cancer. Dr. Dinan currently holds an AHRQ K99/R00 pathway to independence award to examine adoption of Oncotype DX molecular testing in breast cancer and has conducted work in breast and other cancers examining emerging technologies and their associated disparities in utilization, outcomes and costs. Dr. Dinan has expertise in both secondary data analysis and clinical registry methodologies. Her secondary data expertise include the SEER-Medicare linked data, Medicare claims, NIS, NCDB, as well as EHR data.

Dr. Dinan holds additional appointments at the Duke Clinical Research Institute and Duke Cancer Institute where she co-leads the Patient Experience and Survivorship Focus Area in the Cancer Control and Population Sciences Program.

Areas of expertise: Health Economics, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of North Carolina - Chapel Hill, 2011
  • B.S., University of Virginia, 2003

Publications

Dinan, Michaela A., Lauren E. Wilson, Shelby D. Reed, Jennifer J. Griggs, and Edward C. Norton. “Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption.” Clin Breast Cancer, May 26, 2020. https://doi.org/10.1016/j.clbc.2020.05.010.

PMID
32653473
Full Text

Moss, Haley A., Laura J. Havrilesky, Frances F. Wang, Mihaela V. Georgieva, Laura H. Hendrix, and Michaela A. Dinan. “Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer.” J Oncol Pract 15, no. 12 (December 2019): e1018–27. https://doi.org/10.1200/JOP.19.00026.

PMID
31613721
Full Text

Zambeli-Ljepović, Alan, Frances Wang, Michaela A. Dinan, Terry Hyslop, Michael T. Stang, Sanziana A. Roman, Julie A. Sosa, and Randall P. Scheri. “Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.” Surgery 166, no. 5 (November 2019): 895–900. https://doi.org/10.1016/j.surg.2019.05.035.

PMID
31288935
Full Text

Zambeli-Ljepović, Alan, Frances Wang, Michaela A. Dinan, Terry Hyslop, Sanziana A. Roman, Julie Ann Sosa, and Randall P. Scheri. “Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.” J Surg Res 243 (November 2019): 189–97. https://doi.org/10.1016/j.jss.2019.05.029.

PMID
31185435
Full Text

Zambeli-Ljepovic, Alan, Frances Wang, Michaela A. Dinan, Terry Hyslop, Michael T. Stang, Sanziana A. Roman, Julie Ann Sosa, and Randall P. Scheri. “Low Risk Thyroid Cancer in Older Adults: More Extensive Surgery Comes with Increased Cost of Surveillance.” In Journal of the American College of Surgeons, 229:S78–S78. ELSEVIER SCIENCE INC, 2019.

Scholars@Duke

Ramalingam, S., M. Dinan, and J. Crawford. “OA11.03 Survival Disparities Between Academic and Community Centers in Advanced Lung Cancer in the US: Can We Bridge the Gap?” In Journal of Thoracic Oncology, 14:S234–35. Elsevier BV, 2019. https://doi.org/10.1016/j.jtho.2019.08.467.

Full Text

Rotter, Jason, Lauren Wilson, Melissa A. Greiner, Craig E. Pollack, and Michaela Dinan. “Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer.” Breast Cancer Res Treat 176, no. 2 (July 2019): 445–51. https://doi.org/10.1007/s10549-019-05248-2.

PMID
31028607
Full Text

Dinan, Michaela A., Lauren E. Wilson, and Shelby D. Reed. “Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011.” J Natl Compr Canc Netw 17, no. 3 (March 1, 2019): 245–54. https://doi.org/10.6004/jnccn.2018.7097.

PMID
30865923
Full Text

Rotter, J., L. Wilson, M. Greiner, C. Pollack, and M. Dinan. “Abstract P4-09-08: Shared-patient physician networks and their impact on the uptake of genomic testing in early-stage breast cancer.” In Poster Session Abstracts. American Association for Cancer Research, 2019. https://doi.org/10.1158/1538-7445.sabcs18-p4-09-08.

Full Text

Dinan, M. A., G. H. Lyman, R. L. Schilsky, and D. F. Hayes. “Proposal for value-based, tiered reimbursement for tumor biomarker tests to promote innovation and evidence generation.” Jco Precision Oncology 3 (January 1, 2019). https://doi.org/10.1200/PO.19.00210.

Full Text

Pages